Clorox Healthcare will be among the stakeholders participating in a White House Forum tomorrow in support of ongoing public and private efforts to reduce healthcare-associated infections (HAIs), many of which are caused by multidrug-resistant organisms (MDROs). 

Rosie Lyles, MD, MHA, MSc, Clorox Healthcare’s Head of Clinical Affairs, will participate in the White House Forum on Antibiotic Stewardship, a day-long event taking place June 2 to help support implementation of the White House’s comprehensive five-year plan to combat the rise of antibiotic-resistant bacteria. The National Action Plan for Combating Antibiotic-Resistant Bacteria outlines enhanced efforts to prevent and contain outbreaks of antibiotic-resistant infections, maintain the efficacy of current and new antibiotics and develop and deploy next-generation diagnostics, vaccines and other therapeutics.

“We understand the crucial role infection prevention and patient safety efforts play in limiting the spread of MDROs and infections in today’s hospital environment, and I’m honored to work with those in attendance to help inform strategies to curb the rise of antibiotic-resistant bacteria,” said Lyles.

“Clorox Healthcare is a long-standing partner and supporter of the Association for Professionals in Infection Control and Epidemiology (APIC) and the Association for the Healthcare Environment (AHE), and we are proud to lend our expertise in support of the National Action Plan for Combating Antibiotic-Resistant Bacteria,” said Dane Dickson, Director of Research & Development for Clorox Healthcare. “Our participation in the White House Forum reflects Clorox Healthcare’s continued commitment to helping front-line healthcare providers and environmental services professionals fight the spread of infection in their facilities.”